fbpx

Sensus Healthcare Inc

SRTS

$8.56

Closing

▲0.59%

1D

▲262.71%

YTD

SRTS

BBG0074FZS06

Exchange

Sector

Market cap

$139.32M

Volume

64,095

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$139.32M

Analysts' Rating

BUY

Price Target (Mean)

10.67

Total Analysts

3

P/E

15.00

Operating Margin

21.45%

Beta

1.21

Revenue Growth

104.09%

52 week high

$9.32

52 week low

$2.05

Div. Yield

%

EPS Growth

-28.57

Company Profile

Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.